CITIGROUP INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 870 filers reported holding NOVARTIS A G in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$18,813,622
-36.2%
184,701
-36.8%
0.01%
-26.3%
Q2 2023$29,503,640
+8.5%
292,376
-1.1%
0.02%0.0%
Q1 2023$27,190,672
+69.8%
295,551
+67.4%
0.02%
+46.2%
Q4 2022$16,016,274
+25.3%
176,546
+5.0%
0.01%
+44.4%
Q3 2022$12,780,000
-9.3%
168,131
+0.9%
0.01%
-10.0%
Q2 2022$14,092,000
-3.5%
166,711
+0.1%
0.01%
+11.1%
Q1 2022$14,607,000
+8.6%
166,466
+8.3%
0.01%
+28.6%
Q4 2021$13,445,000
-16.0%
153,721
-21.5%
0.01%
-22.2%
Q3 2021$16,008,000
-38.7%
195,737
-31.6%
0.01%
-43.8%
Q2 2021$26,126,000
+10.9%
286,347
+3.9%
0.02%
+6.7%
Q1 2021$23,550,000
-47.2%
275,517
-41.7%
0.02%
-42.3%
Q4 2020$44,613,000
+3.5%
472,449
-4.7%
0.03%
-3.7%
Q3 2020$43,103,000
-1.0%
495,664
-0.6%
0.03%
-20.6%
Q2 2020$43,543,000
-2.4%
498,543
-7.9%
0.03%
-17.1%
Q1 2020$44,610,000
-18.4%
541,048
-6.3%
0.04%
+5.1%
Q4 2019$54,683,000
+17.4%
577,498
+7.7%
0.04%
+5.4%
Q3 2019$46,580,000
-17.8%
536,012
-13.6%
0.04%
-17.8%
Q2 2019$56,642,000
+3.9%
620,327
+9.4%
0.04%
-13.5%
Q1 2019$54,492,000
+36.8%
566,795
+22.1%
0.05%
+30.0%
Q4 2018$39,829,000
+15.4%
464,155
+15.8%
0.04%
+29.0%
Q3 2018$34,527,000
+18.1%
400,730
+3.6%
0.03%
+14.8%
Q2 2018$29,231,000
+2.7%
386,962
+10.2%
0.03%
+12.5%
Q1 2018$28,457,000
+22.3%
351,227
+26.7%
0.02%
+26.3%
Q4 2017$23,272,000
-22.4%
277,183
-20.7%
0.02%
-24.0%
Q3 2017$29,994,000
+45.8%
349,371
+41.7%
0.02%
+38.9%
Q2 2017$20,579,000
-11.7%
246,541
-21.5%
0.02%
-14.3%
Q1 2017$23,318,000
+2.9%
313,969
+0.9%
0.02%
+5.0%
Q4 2016$22,668,000
+56.1%
311,187
+69.2%
0.02%
+42.9%
Q3 2016$14,525,000
-17.2%
183,969
-13.5%
0.01%
-22.2%
Q2 2016$17,549,000
-5.3%
212,681
-16.8%
0.02%
-10.0%
Q1 2016$18,528,000
+7.5%
255,753
+27.7%
0.02%
+17.6%
Q4 2015$17,236,000
+1.8%
200,337
+8.8%
0.02%
+6.2%
Q3 2015$16,927,000
+52.5%
184,165
+63.2%
0.02%
+77.8%
Q2 2015$11,102,000
+27.0%
112,875
+27.4%
0.01%
+12.5%
Q1 2015$8,739,000
-47.8%
88,632
-51.0%
0.01%
-46.7%
Q4 2014$16,747,000
-13.0%
180,728
-11.6%
0.02%
-11.8%
Q3 2014$19,240,000
+7.2%
204,402
+3.1%
0.02%0.0%
Q2 2014$17,944,000
+32.7%
198,221
+24.7%
0.02%
+21.4%
Q1 2014$13,520,000
+19.6%
159,003
+13.1%
0.01%
+40.0%
Q4 2013$11,302,000
+10.1%
140,624
+5.1%
0.01%
+11.1%
Q3 2013$10,265,000
+14.7%
133,817
+5.7%
0.01%0.0%
Q2 2013$8,953,000126,6170.01%
Other shareholders
NOVARTIS A G shareholders Q1 2016
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders